APA
Vander Lugt M. T., Braun T. M., Hanash S., Ritz J., Ho V. T., Antin J. H., Zhang Q., Wong C., Wang H., Chin A., Gomez A., Harris A. C., Levine J. E., Choi S. W., Couriel D., Reddy P., Ferrara J. L. M. & Paczesny S. (20130815). ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. : The New England journal of medicine.
Chicago
Vander Lugt Mark T, Braun Thomas M, Hanash Samir, Ritz Jerome, Ho Vincent T, Antin Joseph H, Zhang Qing, Wong Chee-Hong, Wang Hong, Chin Alice, Gomez Aurélie, Harris Andrew C, Levine John E, Choi Sung W, Couriel Daniel, Reddy Pavan, Ferrara James L M and Paczesny Sophie. 20130815. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. : The New England journal of medicine.
Harvard
Vander Lugt M. T., Braun T. M., Hanash S., Ritz J., Ho V. T., Antin J. H., Zhang Q., Wong C., Wang H., Chin A., Gomez A., Harris A. C., Levine J. E., Choi S. W., Couriel D., Reddy P., Ferrara J. L. M. and Paczesny S. (20130815). ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. : The New England journal of medicine.
MLA
Vander Lugt Mark T, Braun Thomas M, Hanash Samir, Ritz Jerome, Ho Vincent T, Antin Joseph H, Zhang Qing, Wong Chee-Hong, Wang Hong, Chin Alice, Gomez Aurélie, Harris Andrew C, Levine John E, Choi Sung W, Couriel Daniel, Reddy Pavan, Ferrara James L M and Paczesny Sophie. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. : The New England journal of medicine. 20130815.